These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28645757)

  • 21. Renal denervation in heart failure with normal left ventricular ejection fraction. Rationale and design of the DIASTOLE (DenervatIon of the renAl Sympathetic nerves in hearT failure with nOrmal Lv Ejection fraction) trial.
    Verloop WL; Beeftink MM; Nap A; Bots ML; Velthuis BK; Appelman YE; Cramer MJ; Agema WR; Scholtens AM; Doevendans PA; Allaart CP; Voskuil M
    Eur J Heart Fail; 2013 Dec; 15(12):1429-37. PubMed ID: 23883653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Denervation of the renal arteries in metabolic syndrome: the DREAMS-study.
    Verloop WL; Spiering W; Vink EE; Beeftink MM; Blankestijn PJ; Doevendans PA; Voskuil M
    Hypertension; 2015 Apr; 65(4):751-7. PubMed ID: 25646297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of renal denervation on coronary flow reserve and forearm dilation capacity in patients with treatment-resistant hypertension. A randomized, double-blinded, sham-controlled clinical trial.
    Engholm M; Bertelsen JB; Mathiassen ON; Bøtker HE; Vase H; Peters CD; Bech JN; Buus NH; Schroeder AP; Rickers H; Hansen KW; Poulsen PL; Kaltoft A; Christensen KL
    Int J Cardiol; 2018 Jan; 250():29-34. PubMed ID: 29042091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of catheter-based renal denervation on heart failure with reduced ejection fraction: a meta-analysis of randomized controlled trials.
    Fukuta H; Goto T; Wakami K; Kamiya T; Ohte N
    Heart Fail Rev; 2022 Jan; 27(1):29-36. PubMed ID: 32394227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left cardiac sympathetic denervation for treatment of symptomatic systolic heart failure patients: a pilot study.
    Conceição-Souza GE; Pêgo-Fernandes PM; Cruz Fd; Guimarães GV; Bacal F; Vieira ML; Grupi CJ; Giorgi MC; Consolim-Colombo FM; Negrão CE; Rondon MU; Moreira LF; Bocchi EA
    Eur J Heart Fail; 2012 Dec; 14(12):1366-73. PubMed ID: 23099357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Bhardwaj A; Rehman SU; Mohammed A; Baggish AL; Moore SA; Januzzi JL
    Am Heart J; 2010 Apr; 159(4):532-538.e1. PubMed ID: 20362709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of catheter-based renal sympathetic denervation in pigs with rapid pacing induced heart failure].
    Xie Y; Liu Q; Xu Y; Gao J; Yan P; Zhang W; Sun J; Wang M; Jin H; Jiang J; Liu Z
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jan; 42(1):48-52. PubMed ID: 24680270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of renal denervation in patients with heart failure with reduced ejection fraction (HFrEF): A systematic review and meta-analysis.
    Xia Z; Han L; Pellegrino PR; Schiller AM; Harrold LD; Lobato RL; Lisco SJ; Zucker IH; Wang HJ
    Heliyon; 2022 Jan; 8(1):e08847. PubMed ID: 35141435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
    Fadl Elmula FE; Jin Y; Yang WY; Thijs L; Lu YC; Larstorp AC; Persu A; Sapoval M; Rosa J; Widimský P; Jacobs L; Renkin J; Petrák O; Chatellier G; Shimada K; Widimský J; Kario K; Azizi M; Kjeldsen SE; Staessen JA;
    Blood Press; 2015; 24(5):263-74. PubMed ID: 26194721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A perspective on sympathetic renal denervation in chronic congestive heart failure.
    Madanieh R; El-Hunjul M; Alkhawam H; Kosmas CE; Madanieh A; Vittorio TJ
    Heart Fail Rev; 2016 Jan; 21(1):1-10. PubMed ID: 26563322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
    Schlaich MP; Bart B; Hering D; Walton A; Marusic P; Mahfoud F; Böhm M; Lambert EA; Krum H; Sobotka PA; Schmieder RE; Ika-Sari C; Eikelis N; Straznicky N; Lambert GW; Esler MD
    Int J Cardiol; 2013 Oct; 168(3):2214-20. PubMed ID: 23453868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal and cardiac function for long-term (10 year) risk stratification after myocardial infarction.
    Palmer SC; Yandle TG; Frampton CM; Troughton RW; Nicholls MG; Richards AM
    Eur Heart J; 2009 Jun; 30(12):1486-94. PubMed ID: 19389787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal Denervation Prevents Heart Failure Progression Via Inhibition of the Renin-Angiotensin System.
    Sharp TE; Polhemus DJ; Li Z; Spaletra P; Jenkins JS; Reilly JP; White CJ; Kapusta DR; Lefer DJ; Goodchild TT
    J Am Coll Cardiol; 2018 Nov; 72(21):2609-2621. PubMed ID: 30466519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
    Lenski M; Mahfoud F; Razouk A; Ukena C; Lenski D; Barth C; Linz D; Laufs U; Kindermann I; Böhm M
    Int J Cardiol; 2013 Nov; 169(6):418-24. PubMed ID: 24157238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients.
    Vink EE; Verloop WL; Siddiqi L; van Schelven LJ; Liam Oey P; Blankestijn PJ
    Int J Cardiol; 2014 Sep; 176(1):8-12. PubMed ID: 25027168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial.
    Courand PY; Pereira H; Del Giudice C; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Vehier C; Lantelme P; Denolle T; Dourmap C; Halimi JM; Girerd X; Rossignol P; Zannad F; Ormezzano O; Vaisse B; Herpin D; Ribstein J; Bouhanick B; Mourad JJ; Ferrari E; Chatellier G; Sapoval M; Azarine A; Azizi M;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal denervation ameliorates the risk of ventricular fibrillation in overweight and heart failure.
    Yamada S; Lo LW; Chou YH; Lin WL; Chang SL; Lin YJ; Liu SH; Cheng WH; Tsai TY; Chen SA
    Europace; 2020 Apr; 22(4):657-666. PubMed ID: 31995176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of renal denervation on end organ damage in hypertensive patients.
    Verloop WL; Vink EE; Spiering W; Blankestijn PJ; Doevendans PA; Bots ML; Vonken EJ; Voskuil M; Leiner T
    Eur J Prev Cardiol; 2015 May; 22(5):558-67. PubMed ID: 25326543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.